Felodip 10mg 30 tablets — Made in Germany — Free Delivery

Essential arterial hypertension prophylactic treatment of chronic stable angina pectoris.

Arterial hypertension adults (including elderly patients): the dosing regimen is determined individually.

Therapy begins with a dose of 5 mg 1 time per day. If necessary, the dose can be reduced to 2.5 mg or increased, or another antihypertensive preparation added. As a rule, the maintenance dose is 5-10 mg 1 time per day.

Angina. The dosage regimen is always determined individually.

Therapy begins with a dose of 5 mg 1 time per day. If necessary, this dose can be increased to 10 mg 1 time per day. The maximum dose is 20 mg / day.

In patients with impaired renal function, changes in pharmacokinetics are insignificant, so dose adjustment is not required.

In patients with hypertension and angina pectoris with severe hepatic impairment, the therapeutic dose of felodipine should be reduced (recommended dose 2.5 mg / day).

For the elderly, an initial dose of 2.5 mg once daily may be sufficient.

the preparation is taken in the morning, before meals or after a light breakfast. Tablets are not chewed, divided or crushed. Tablets must be swallowed whole and washed down with water.

Allergic reaction to felodipine and other dihydropyridines (theoretical risk of cross-reactivity) or to other components of the preparation; decompensated heart failure; unstable angina; acute myocardial infarction; dynamic obstruction of the outflow tract of the left ventricle. clinically significant aortic stenosis.

Like other calcium channel blockers, the preparation can cause flushing of the face, headache, palpitations, dizziness and fatigue. these reactions are temporary and often appear at the beginning of treatment and / or when the dose is increased. Also, depending on the dose, swelling in the ankles may occur, which is a consequence of precapillary vasodilation, and not a tendency to fluid retention in the body. in patients with gingival inflammation or periodontitis, gum abscess may occur. this can be avoided with proper oral hygiene. as with the use of other dihydropyridines, in rare cases, worsening of the manifestations of angina pectoris was noted, mainly at the beginning of treatment.

The following side effects have been reported in clinical trials and post-registration preparation monitoring.

From the immune system: hypersensitivity reactions (urticaria and angioedema).

From the nervous system: headache, sleep disturbance, drowsiness, dizziness, paresthesia, anxiety, irritability, confusion, depression.

From the respiratory system: shortness of breath, nosebleeds.

From the side of the cardiovascular system: increased manifestations of angina pectoris (especially at the beginning of treatment), mainly in patients with symptomatic coronary artery disease, syncope, a feeling of increased heart rate, tachycardia, myocardial infarction. Peripheral edema (the degree of swelling in the ankles depends on the dose), arterial hypotension, leukocytoclastic vasculitis.

From the reproductive system: sexual dysfunction.

From the urinary system: frequent urination.

From the digestive system: nausea, gingivitis, gum hyperplasia, abdominal pain, vomiting, periodontitis, diarrhea, constipation, dry mouth.

From the side of liver and gallbladder function: increased levels of liver enzymes, cholestatic hepatitis.